Deals
Explore the dynamic landscape of pharma deals, mergers, acquisitions, and partnerships. Stay informed about strategic collaborations, licensing agreements, and investments shaping the industry. Get insights into the business side of pharmaceuticals and discover the key players driving innovation and growth.
CanSino Biologics eyes more mRNA vaccine deals after AstraZeneca pact
CanSino’s recent collaboration with AstraZeneca in mRNA manufacturing is just the beginning of their ambitions in this field, according to ...
BMS acquires regional rights to Zenasā obexelimab, a bifunctional antibody for autoimmune diseases
Zenas BioPharma has made a strategic move by transferring regional rights for its bifunctional monoclonal antibody, obexelimab. Bristol Myers Squibb ...
Otsuka acquires Mindset Pharma, a leader in psychedelic medicines for mental health
Japanese pharmaceutical giant Otsuka is embarking on a groundbreaking acquisition, setting its sights on Canada’s Mindset Pharma, a specialist in ...
Serina Therapeutics merges with struggling AgeX Therapeutics to go public and advance its Parkinsonās drug
AgeX Therapeutics, a biotech that has been facing financial difficulties and stalled preclinical programs for years, has finally found a ...
Novo Nordisk acquires Embark Biotech for 15 million euros in obesity deal spree
Novo Nordisk has made another move to expand its obesity portfolio, acquiring Embark Biotech for 15 million euros ($16 million) ...
Sandoz Acquires Mycamine, a Top Antifungal Drug, from Astellas
In the ever-evolving landscape of medical advancements, Sandoz emerges as a dominant force, orchestrating a strategic move that echoes across ...
Bristol Myers Squibb’s Bold Robotic Alliance with Cellares for Advanced CAR-T Production
In the realm of cutting-edge cell therapy, where innovation is the heartbeat and the promise of transformative treatments is the ...
Abcam’s Harmonious Acquisition by Danaher Shaping the Future of Antibody Research
In the realm where science meets commerce, a symphony of strategy and innovation is playing out. Just two months since ...
Ferring Strikes $500M Agreement with Royalty Pharma for Innovative Bladder Cancer Gene Therapy
Royalty Pharma has carved a distinctive niche in the pharmaceutical landscape, specializing in identifying innovative products both pre- and post-approval, ...
CARsgen and Moderna Join Forces to Explore Synergy Between CT041 and mRNA Cancer Vaccine
CARsgen Therapeutics has set the stage for an intriguing partnership with Moderna that’s bound to heat up the cancer therapy ...
LEO Pharma Set to Acquire Timber Pharmaceuticals
Timber Pharmaceuticals has exciting news to shareāthe company is set to be acquired by LEO US Holding, Inc., a wholly-owned ...
Chiesi Teams Up with Aliada to Advance Brain-Penetrating Therapies for Central Nervous System Disorders
Chiesi Pharma, a specialist in rare diseases, has entered into a strategic collaboration with US biotech company Aliada Therapeutics. The ...
Biogen Outbids Competitor in $7.3 Billion Reata Pharmaceuticals Acquisition Duel
In a surprising turn of events, Biogen’s acquisition of Reata Pharmaceuticals for $7.3 billion raised eyebrows among industry observers last ...
GeneFab Secures $38 Million Deal to Utilize Senti Biosciences’ Advanced Manufacturing Facility
In a major development, GeneFab, a newly established organization specializing in contract research, development, and manufacturing for cell and gene ...
Novartis Acquires Chinook Therapeutics for USD 3.5 Billion to Boost its Renal Portfolio
Novartis, a global pharmaceutical giant, has finalized its deal to buy Chinook Therapeutics, a biotech company that specializes in developing ...
eureKING purchases SCTbio to further its bio manufacturing initiative
eureKING, a special purpose acquisition company (SPAC) established last year with a substantial investment of over ā¬150 million, has finalized ...
SK Bioscience invests $85M on a 7% share in the vaccine manufacturer, Novavax, to keep it afloat
Following its setback during the pandemic phase of COVID-19 with a delayed vaccine, Novavax is now aiming for recovery in ...
Revolutionizing Biologics Manufacturing with $490M Partnership: Merck and Ginkgo Bioworks Join Forces
Source – Ginkgo Bioworks As part of this agreement, Ginkgo will contribute its expertise in cell engineering, ultra-high-throughput multiplexed screening, ...
To restock the US with smallpox and mpox vaccines, Bavarian Nordic signs a $120 million BARDA contract
Source – Bavarian Nordic Vaccine manufacturer Bavarian Nordic, which played a crucial role in combating the mpox outbreak in 2022, ...
Even after buying Prometheus for $10.8 billion, Merck is still looking for M&A opportunities
Earlier this year, Merck’s acquisition of Prometheus Biosciences for $10.8 billion provided the New Jersey company with a much-needed diversification ...
TG Therapeutics Partners with Neuraxpharm to Launch Game-Changing Multiple Sclerosis Antibody Briumvi Worldwide
After gaining approval for Briumvi in the US eight months ago, TG Therapeutics is now set to introduce its multiple ...
Qunol, a rapidly expanding US brand in the healthy aging market, will be acquired by Sanofi
Source – Sanofi Paris, July 28, 2023. Sanofi announces its strategic move to acquire Qunol, a renowned and leading brand ...
Expanding their strategic partnership, AbbVie and Calibr aim to advance a number of preclinical and early-stage clinical assets
Source – AbbVie On July 26, 2023, AbbVie and Calibr announced expanded strategic collaboration to advance several innovative preclinical and ...
Eversana and Amazon are planning an AI-driven drug push
Source – Eversana Eversana and Amazon Web Services (AWS) have formed an alliance to accelerate the adoption of generative artificial ...
With the PeptiDream agreement, Astellas incorporates protein degraders
Source – AstellasĀ Astellas has continued its focus on protein degrader drugs, announcing its second partnership in this category in ...
Teva Expands Alvotech Collaboration with 2 New Biosimilar, $40M Investment & Enhanced Oversight
Source – Teva Pharmaceuticals Following the second FDA rejection of Teva’s Alvotech-partnered biosimilar for Humira, the two companies are expanding ...
Powerful Alliance: AstraZeneca Teams Up with SK Chemicals to Revolutionize Diabetes Treatment with Sidapvia Combo Drug
Korea’s SK Chemicals has recently entered into an agreement with AstraZeneca to manufacture the diabetes drug Sidapvia for the remainder ...
Roche & Alnylam partner: Hypertension RNAi Therapy – Zilebesiran
Source – Roche Roche has recently unveiled an exciting collaboration with Alnylam to jointly develop and commercialize zilebesiran, a promising ...
In a $466 million agreement, Sosei acquires the Japan and Korea subsidiaries of Idorsia
Source – Sosei Heptares Japan’s Sosei Group has successfully transformed into a commercial-stage pharmaceutical company by acquiring the rights to ...
Astellas and Eko Partner for Heart Failure Digital Therapeutics with Eko CORE 500ā¢ Stethoscope
Source – Astellas Pharma Astellas has obtained the licensing rights to a smart stethoscope device developed by Eko Health, with ...
